1. Document
     BC CDA ClinicalDocumentDischargeSummary (V3) (2.16.840.1.113883.3.51.60.2.4)
    1. Header
       BC CDA Ordering Provider (2.16.840.1.113883.3.51.60.1.9.2)
      1. Header
         BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
    2. Entry
       CDA Place (2.16.840.1.113883.10.12.317)
    3. Section
       BC CDA Allergies and Intolerances Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.8)
      1. Entry
         BC CDA Allergy Concern Act (V3) (2.16.840.1.113883.3.51.60.3.7)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        2. Entry
           BC CDA Allergy - Intolerance Observation (V2) (2.16.840.1.113883.3.51.60.3.6)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          2. Entry
             BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
            1. Entry
               BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
              1. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.2.86)
              2. Entry
                 Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
              5. Entry
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
                1. Entry
                   Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
            2. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
          4. Entry
             Criticality Observation (2.16.840.1.113883.10.20.22.2.84)
    4. Section
       Hospital Course Section (1.3.6.1.4.1.19376.1.5.3.1.3.5)
    5. Section
       BC CDA Discharge Diagnosis Section (V3) (2.16.840.1.113883.3.51.60.3.19)
      1. Entry
         BC CDA Hospital Discharge Diagnosis (V3) (2.16.840.1.113883.3.51.60.3.18)
        1. Entry
           BC CDA Problem Observation (V3) (2.16.840.1.113883.3.51.60.3.9)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          2. Entry
             Age Observation (2.16.840.1.113883.10.20.22.2.63)
          3. Entry
             Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
          4. Entry
             BC CDA Principle Diagnosis (2.16.840.1.113883.3.51.60.3.10)
    6. Section
       BC CDA Discharge Medications Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.17)
      1. Entry
         BC CDA Discharge Medication (V2) (2.16.840.1.113883.3.51.60.3.16)
        1. Entry
           BC CDA Medication Activities (V2) (2.16.840.1.113883.3.51.60.3.13)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
          2. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.2.65)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.2.69)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
            3. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          8. Entry
             BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
            1. Entry
               BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
              1. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.2.86)
              2. Entry
                 Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
              5. Entry
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
                1. Entry
                   Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
            2. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
          9. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.2.70)
    7. Section
       BC CDA Plan of Treatment Section (V2) (2.16.840.1.113883.3.51.60.3.36)
      1. Entry
         BC CDA Planned Observation (V2) (2.16.840.1.113883.3.51.60.3.29)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        2. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
        4. Entry
           Planned Coverage (2.16.840.1.113883.10.20.22.2.126)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
      2. Entry
         BC CDA Planned Encounter (V2) (2.16.840.1.113883.3.51.60.3.32)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.2.114)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
      3. Entry
         BC CDA Planned Act (V2) (2.16.840.1.113883.3.51.60.3.31)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        2. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
      4. Entry
         BC CDA Planned Procedure (V2) (2.16.840.1.113883.3.51.60.3.33)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        2. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
        4. Entry
           BC CDA Planned Coverage (2.16.840.1.113883.3.51.60.3.30)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
      5. Entry
         BC CDA Planned Medication Activity (V2) (2.16.840.1.113883.3.51.60.3.34)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
        5. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.2.85)
      6. Entry
         BC CDA Planned Supply (V2) (2.16.840.1.113883.3.51.60.3.35)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
        2. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
        3. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        4. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        5. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
        6. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
        7. Entry
           BC CDA Planned Coverage (2.16.840.1.113883.3.51.60.3.30)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
      7. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
      8. Entry
         BC CDA Handoff Communication Participants (2.16.840.1.113883.3.51.60.3.37)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
      9. Entry
         BC CDA Nutrition Recommendation (2.16.840.1.113883.3.51.60.3.38)
        1. Entry
           BC CDA Planned Encounter (V2) (2.16.840.1.113883.3.51.60.3.32)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          2. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.2.114)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
        2. Entry
           BC CDA Planned Medication Activity (V2) (2.16.840.1.113883.3.51.60.3.34)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          5. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.2.85)
        3. Entry
           BC CDA Planned Observation (V2) (2.16.840.1.113883.3.51.60.3.29)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          2. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          4. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.2.126)
            1. Entry
               BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
              1. Header
                 BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
              2. Header
                 BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        4. Entry
           BC CDA Planned Procedure (V2) (2.16.840.1.113883.3.51.60.3.33)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          2. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          4. Entry
             BC CDA Planned Coverage (2.16.840.1.113883.3.51.60.3.30)
            1. Entry
               BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
              1. Header
                 BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
              2. Header
                 BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        5. Entry
           BC CDA Planned Supply (V2) (2.16.840.1.113883.3.51.60.3.35)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
          3. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          4. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          5. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
          6. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          7. Entry
             BC CDA Planned Coverage (2.16.840.1.113883.3.51.60.3.30)
            1. Entry
               BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
              1. Header
                 BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
              2. Header
                 BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        6. Entry
           BC CDA Planned Act (V2) (2.16.840.1.113883.3.51.60.3.31)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          2. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
      10. Entry
         BC CDA Planned Immunization Activity (2.16.840.1.113883.3.51.60.3.39)
        1. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
        2. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
        5. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.2.85)
      11. Entry
         BC CDA Goal Observation (2.16.840.1.113883.3.51.60.3.40)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        2. Entry
           Entry Reference (2.16.840.1.113883.10.20.22.4.122)
        3. Entry
           Entry Reference (2.16.840.1.113883.10.20.22.4.122)
        4. @
           BC CDA Goal Observation (2.16.840.1.113883.3.51.60.3.40)
        5. Entry
           Entry Reference (2.16.840.1.113883.10.20.22.4.122)
        6. Entry
           External Document Reference (2.16.840.1.113883.10.20.22.4.115)
    8. Section
       Chief Complaint Section (2.16.840.1.113883.10.20.22.2.45)
    9. Section
       Reason for Visit Section (2.16.840.1.113883.10.20.22.2.46)
    10. Section
       Discharge Diet Section (1.3.6.1.4.1.19376.1.5.3.1.3.33)
    11. Section
       Family History Section (V3) (2.16.840.1.113883.10.20.22.2.15)
      1. Entry
         Family History Organizer (V3) (2.16.840.1.113883.10.20.22.4.45)
        1. Entry
           Family History Observation (V3) (2.16.840.1.113883.10.20.22.4.46)
          1. Entry
             Age Observation (2.16.840.1.113883.10.20.22.4.31)
          2. Entry
             Family History Death Observation (2.16.840.1.113883.10.20.22.4.47)
    12. Section
       Functional Status Section (V2) (2.16.840.1.113883.10.20.22.2.14)
      1. Entry
         Functional Status Organizer (V2) (2.16.840.1.113883.10.20.22.4.66)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Functional Status Observation (V2) (2.16.840.1.113883.10.20.22.4.67)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
            1. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            2. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          3. Entry
             Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
          4. Entry
             Assessment Scale Observation (2.16.840.1.113883.10.20.22.4.69)
            1. Entry
               Assessment Scale Supporting Observation (2.16.840.1.113883.10.20.22.4.86)
        3. Entry
           Self-Care Activities (ADL and IADL) (2.16.840.1.113883.10.20.22.4.128)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Functional Status Observation (V2) (2.16.840.1.113883.10.20.22.4.67)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
          1. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          2. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        3. Entry
           Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
        4. Entry
           Assessment Scale Observation (2.16.840.1.113883.10.20.22.4.69)
          1. Entry
             Assessment Scale Supporting Observation (2.16.840.1.113883.10.20.22.4.86)
      3. Entry
         Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
      4. Entry
         Assessment Scale Observation (2.16.840.1.113883.10.20.22.4.69)
        1. Entry
           Assessment Scale Supporting Observation (2.16.840.1.113883.10.20.22.4.86)
      5. Entry
         Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
        1. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        2. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      6. Entry
         Self-Care Activities (ADL and IADL) (2.16.840.1.113883.10.20.22.4.128)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      7. Entry
         Sensory Status (2.16.840.1.113883.10.20.22.4.127)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Assessment Scale Observation (2.16.840.1.113883.10.20.22.4.69)
          1. Entry
             Assessment Scale Supporting Observation (2.16.840.1.113883.10.20.22.4.86)
      8. Entry
         Cognitive Status Problem Observation (DEPRECATED) (2.16.840.1.113883.10.20.22.4.73)
      9. Entry
         Functional Status Problem Observation (DEPRECATED) (2.16.840.1.113883.10.20.22.4.68)
      10. Entry
         Pressure Ulcer Observation (DEPRECATED) (2.16.840.1.113883.10.20.22.4.70)
    13. Section
       History of Present Illness Section (1.3.6.1.4.1.19376.1.5.3.1.3.4)
    14. Section
       BC CDA Admission Diagnosis Section (V3) (2.16.840.1.113883.3.51.60.3.23)
      1. Entry
         BC CDA Hospital Admission Diagnosis (V3) (2.16.840.1.113883.3.51.60.3.22)
        1. Entry
           BC CDA Problem Observation (V3) (2.16.840.1.113883.3.51.60.3.9)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          2. Entry
             Age Observation (2.16.840.1.113883.10.20.22.2.63)
          3. Entry
             Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
          4. Entry
             BC CDA Principle Diagnosis (2.16.840.1.113883.3.51.60.3.10)
    15. Section
       BC CDA Admission Medications Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.21)
      1. Entry
         BC CDA Admission Medication (V2) (2.16.840.1.113883.3.51.60.3.20)
        1. Entry
           BC CDA Medication Activities (V2) (2.16.840.1.113883.3.51.60.3.13)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
          2. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.2.65)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.2.69)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
            3. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
          8. Entry
             BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
            1. Entry
               BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
              1. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.2.86)
              2. Entry
                 Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
              5. Entry
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
                1. Entry
                   Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
            2. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
          9. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.2.70)
    16. Section
       Hospital Consultations Section (2.16.840.1.113883.10.20.22.2.42)
    17. Section
       Hospital Discharge Instructions Section (2.16.840.1.113883.10.20.22.2.41)
    18. Section
       Hospital Discharge Physical Section (1.3.6.1.4.1.19376.1.5.3.1.3.26)
    19. Section
       Hospital Discharge Studies Summary Section (2.16.840.1.113883.10.20.22.2.16)
    20. Section
       BC CDA Immunizations Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.25)
      1. Entry
         BC CDA Immunization Activity (V3) (2.16.840.1.113883.3.51.60.3.24)
        1. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
        2. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.2.65)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.2.69)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
          3. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.2.72)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.2.71)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.2.91)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
        8. Entry
           BC CDA Reaction Observation (V2) (2.16.840.1.113883.3.51.60.3.3)
          1. Entry
             BC CDA Procedure Activity Procedure (V2) (2.16.840.1.113883.3.51.60.3.4)
            1. Entry
               Product Instance (2.16.840.1.113883.10.20.22.2.86)
            2. Entry
               Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.2.68)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.2.67)
            5. Entry
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.2.58)
              1. Entry
                 Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
          2. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.2.59)
        9. Entry
           Immunization Refusal Reason (2.16.840.1.113883.10.20.22.2.92)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.2.76)
        11. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.2.85)
    21. Section
       BC CDA Problem Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.12)
      1. Entry
         BC CDA Problem Concern Act (V3) (2.16.840.1.113883.3.51.60.3.11)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        2. Entry
           BC CDA Problem Observation (V3) (2.16.840.1.113883.3.51.60.3.9)
          1. Entry
             BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
            1. Header
               BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
            2. Header
               BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
          2. Entry
             Age Observation (2.16.840.1.113883.10.20.22.2.63)
          3. Entry
             Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
          4. Entry
             BC CDA Principle Diagnosis (2.16.840.1.113883.3.51.60.3.10)
      2. Entry
         Health Status Observation (V2) (2.16.840.1.113883.10.20.22.2.94)
    22. Section
       Procedures Section (entries optional) (V2) (2.16.840.1.113883.10.20.22.2.7)
      1. Entry
         Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        3. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        6. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. @
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        7. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. @
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          2. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      2. Entry
         Procedure Activity Observation (V2) (2.16.840.1.113883.10.20.22.4.13)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        6. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. Entry
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              3. Entry
                 Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              5. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              6. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              7. Entry
                 Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. datatypelevel
                   US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                4. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              8. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              9. Entry
                 Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                1. datatypelevel
                   US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
              10. Entry
                 Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
              11. Entry
                 Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
              12. Entry
                 Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      3. Entry
         Procedure Activity Act (V2) (2.16.840.1.113883.10.20.22.4.12)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    23. Section
       Review of Systems Section (1.3.6.1.4.1.19376.1.5.3.1.3.18)
    24. Section
       Social History Section (V3) (2.16.840.1.113883.10.20.22.2.17)
      1. Entry
         Social History Observation (V3) (2.16.840.1.113883.10.20.22.4.38)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Pregnancy Observation (2.16.840.1.113883.10.20.15.3.8)
        1. Entry
           Estimated Date of Delivery (2.16.840.1.113883.10.20.15.3.1)
      3. Entry
         Smoking Status - Meaningful Use (V2) (2.16.840.1.113883.10.20.22.4.78)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      4. Entry
         Tobacco Use (V2) (2.16.840.1.113883.10.20.22.4.85)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      5. Entry
         Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
      6. Entry
         Cultural and Religious Observation (2.16.840.1.113883.10.20.22.4.111)
      7. Entry
         Characteristics of Home Environment (2.16.840.1.113883.10.20.22.4.109)
    25. Section
       Vital Signs Section (entries optional) (V3) (2.16.840.1.113883.10.20.22.2.4)
      1. Entry
         Vital Signs Organizer (V3) (2.16.840.1.113883.10.20.22.4.26)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Vital Sign Observation (V2) (2.16.840.1.113883.10.20.22.4.27)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
    26. Section
       Advance Directives Section (entries optional) (V3) (2.16.840.1.113883.10.20.22.2.48)
    27. Section
       BC CDA Results Section (entries optional) (V3) (2.16.840.1.113883.3.51.60.3.41)
    28. Section
       BC CDA Complications DS Section (V3) (2.16.840.1.113883.3.51.60.3.15)
      1. Entry
         BC CDA Problem Observation (V3) (2.16.840.1.113883.3.51.60.3.9)
        1. Entry
           BC CDA Author (Body) (2.16.840.1.113883.3.51.60.3.5)
          1. Header
             BC CDA Person (2.16.840.1.113883.3.51.60.1.5.2)
          2. Header
             BC CDA Organization (2.16.840.1.113883.3.51.60.1.5.1)
        2. Entry
           Age Observation (2.16.840.1.113883.10.20.22.2.63)
        3. Entry
           Prognosis Observation (2.16.840.1.113883.10.20.22.2.75)
        4. Entry
           BC CDA Principle Diagnosis (2.16.840.1.113883.3.51.60.3.10)